OurInsightsTitle

Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

From Early Access to Routine Reimbursement: How Does the SMC Ultra-Orphan Pathway Address Evidence Gaps to Support Reimbursement Decisions?

Register to access the Tolley insights